Increased intravitreous interleukin-18 correlated to vascular endothelial growth factor in patients with active proliferative diabetic retinopathy
Authors:
- 15 February 2014
- journal article
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 252 (8) , 1229-1234
Abstract
To determine the intravitreous levels of interleukin-18 (IL-18) and vascular endothelial growth factor (VEGF) in patients with proliferative diabetic retinopathy (PDR) and to ascertain their association with PDR activity. Thirty eyes of 30 diabetic patients with PDR were divided into two groups (active PDR, n = 17; quiescent PDR, n = 13). Fifteen eyes of 15 non-diabetic patients (macular hole, n = 9; epiretinal membrane, n = 6) served as controls. All vitreous fluid samples were obtained during vitrectomy. IL-18 and VEGF were measured by enzyme-linked immunosorbent assay. Serum glycosylated hemoglobin as well as the basic demographic data was documented. Both IL-18 and VEGF levels were higher in patients with PDR than control (P < 0 .01 and P < 0 .01, respectively). Both IL-18 and VEGF in active PDR were higher than those in quiescent PDR (P = 0.048 and P = 0.03, respectively). A significant positive correlation (Spearman rank correlation coefficient (r s) = 0.502, P = 0.005) between IL-18 and VEGF was observed in all PDR patients but not in the control. The correlation between VEGF and IL-18 was even stronger in the subgroup of active PDR (r s = 0.684; P = 0.002), whereas no significant correlation was found in the subgroup of quiescent PDR (r s = 0.049; P = 0.873). Both intravitreous IL-18 and VEGF were elevated in patients with PDR, which were closely correlated in active PDR. IL-18 may contribute to retinal angiogenesis by acting together with or via VEGF, and become the potential therapeutic target for treatment of PDR.Keywords
This publication has 27 references indexed in Scilit:
- Effect of Intravitreal Bevacizumab on Vascular Endothelial Growth Factor Expression in Patients with Proliferative Diabetic RetinopathyYonsei Medical Journal, 2011
- The role of vascular endothelial growth factor in the progression of diabetic vascular complicationsEye, 2010
- Alterations in the Intraocular Cytokine Milieu after Intravitreal BevacizumabInvestigative Ophthalmology & Visual Science, 2010
- The Angio-Fibrotic Switch of VEGF and CTGF in Proliferative Diabetic RetinopathyPLOS ONE, 2008
- Interleukin‐18 induces angiogenic factors in rheumatoid arthritis synovial tissue fibroblasts via distinct signaling pathwaysArthritis & Rheumatism, 2007
- Effects of adenosine on adhesion molecule expression and cytokine production in human PBMC depend on the receptor subtype activatedBritish Journal of Pharmacology, 2007
- Interleukin-18 regulates pathological intraocular neovascularizationJournal of Leukocyte Biology, 2007
- Interleukin-18 induces the production of vascular endothelial growth factor (VEGF) in rheumatoid arthritis synovial fibroblasts via AP-1-dependent pathwaysImmunology Letters, 2006
- A central role for inflammation in the pathogenesis of diabetic retinopathyThe FASEB Journal, 2004
- Expression of Interleukin (IL)-18 and Functional IL-18 Receptor on Human Vascular Endothelial Cells, Smooth Muscle Cells, and MacrophagesJournal of Experimental Medicine, 2002